Reported Mar 8, 2023 · Terminated

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by:…

The Harvard Drug Group

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: The Harvard Drug Group · 341 Mason Rd · La Vergne, TN · 37086-3606

Is this the product you have?

  • Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only
  • Manufactured in Czech Republic byTeva Czech Industries, s.r.o. Opava-Komarov, Czech Republic
  • Manufactured forTeva Pharmaceuticals USA, Inc. Parsippany, NJ 07054
  • Packaged and Distributed by
    • Major Pharmaceuticals Indianapolis
    • IN 46268 USA. NDC 0904-7257-61
    • UPC 3 09047 25761 4
Lot codes and dates
  • LotM04145 Exp. 01/2024
Amount recalled
17,586 cartons

Where it was sold

  • Nationwide

Why it was recalled

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new The Harvard Drug Group recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Apr 30, 2024 · Data as of Sep 19, 6:37 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.